HEADER HYDROLASE/HYDROLASE INHIBITOR 07-MAY-98 1BDA
TITLE CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN
TITLE 2 COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE)
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SINGLE CHAIN TISSUE TYPE PLASMINOGEN ACTIVATOR;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: UNP RESIDUES 298-562;
COMPND 5 SYNONYM: SC-TPA;
COMPND 6 EC: 3.4.21.68;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS TRYPSIN LIKE SERINE PROTEASE, FIBRINOLYTIC ENZYMES, PLASMINOGEN
KEYWDS 2 ACTIVATORS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR W.BODE,M.RENATUS,R.A.ENGH
REVDAT 5 16-OCT-24 1BDA 1 REMARK
REVDAT 4 02-AUG-23 1BDA 1 COMPND REMARK HETNAM LINK
REVDAT 3 13-JUL-11 1BDA 1 VERSN
REVDAT 2 24-FEB-09 1BDA 1 VERSN
REVDAT 1 11-MAY-99 1BDA 0
JRNL AUTH M.RENATUS,R.A.ENGH,M.T.STUBBS,R.HUBER,S.FISCHER,U.KOHNERT,
JRNL AUTH 2 W.BODE
JRNL TITL LYSINE 156 PROMOTES THE ANOMALOUS PROENZYME ACTIVITY OF TPA:
JRNL TITL 2 X-RAY CRYSTAL STRUCTURE OF SINGLE-CHAIN HUMAN TPA.
JRNL REF EMBO J. V. 16 4797 1997
JRNL REFN ISSN 0261-4189
JRNL PMID 9305622
JRNL DOI 10.1093/EMBOJ/16.16.4797
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH M.RENATUS,M.T.STUBBS,R.HUBER,P.BRINGMANN,P.DONNER,
REMARK 1 AUTH 2 W.D.SCHLEUNING,W.BODE
REMARK 1 TITL CATALYTIC DOMAIN STRUCTURE OF VAMPIRE BAT PLASMINOGEN
REMARK 1 TITL 2 ACTIVATOR: A MOLECULAR PARADIGM FOR PROTEOLYSIS WITHOUT
REMARK 1 TITL 3 ACTIVATION CLEAVAGE
REMARK 1 REF BIOCHEMISTRY V. 36 13483 1997
REMARK 1 REFN ISSN 0006-2960
REMARK 1 REFERENCE 2
REMARK 1 AUTH D.LAMBA,M.BAUER,R.HUBER,S.FISCHER,R.RUDOLPH,U.KOHNERT,W.BODE
REMARK 1 TITL THE 2.3 A CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF
REMARK 1 TITL 2 RECOMBINANT TWO-CHAIN HUMAN TISSUE-TYPE PLASMINOGEN
REMARK 1 TITL 3 ACTIVATOR
REMARK 1 REF J.MOL.BIOL. V. 258 117 1996
REMARK 1 REFN ISSN 0022-2836
REMARK 2
REMARK 2 RESOLUTION. 3.35 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 3.851
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.35
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.2500
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 81.0
REMARK 3 NUMBER OF REFLECTIONS : 6845
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NO FREE R-FACTOR
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING SET) : NULL
REMARK 3 FREE R VALUE : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 10
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.25
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.35
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 29.00
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 240
REMARK 3 BIN R VALUE (WORKING SET) : 0.3110
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4170
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 82
REMARK 3 SOLVENT ATOMS : 19
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.10
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.671
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.74
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.386
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 2.090 ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.581 ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : 2.661 ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.228 ; NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO
REMARK 3 PARAMETER FILE 2 : PARAM19.SOL
REMARK 3 PARAMETER FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1BDA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 100 THE DEPOSITION ID IS D_1000171616.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 13-JUN-96
REMARK 200 TEMPERATURE (KELVIN) : 290
REMARK 200 PH : 8.2
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : GRAPHITE(002)
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, ROTAGR
REMARK 200 DATA SCALING SOFTWARE : ROTAGR
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9414
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100
REMARK 200 RESOLUTION RANGE LOW (A) : 25.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 86.7
REMARK 200 DATA REDUNDANCY : 2.900
REMARK 200 R MERGE (I) : 0.14700
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 3.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.18
REMARK 200 COMPLETENESS FOR SHELL (%) : 55.2
REMARK 200 DATA REDUNDANCY IN SHELL : 1.70
REMARK 200 R MERGE FOR SHELL (I) : 0.63000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.200
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: NULL
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: X-PLOR 3.851
REMARK 200 STARTING MODEL: 1RTF
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 48.00
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.2
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.99500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.58000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.39000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.58000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.99500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.39000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 475
REMARK 475 ZERO OCCUPANCY RESIDUES
REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY.
REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT
REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE)
REMARK 475 M RES C SSEQI
REMARK 475 LYS A 36
REMARK 475 HIS A 37
REMARK 475 ARG A 37A
REMARK 475 ARG A 37B
REMARK 475 SER A 37C
REMARK 475 PRO A 37D
REMARK 475 ARG A 110D
REMARK 475 GLY A 186C
REMARK 475 GLY A 186D
REMARK 475 PRO A 186E
REMARK 475 PRO A 244
REMARK 475 THR B 1A
REMARK 475 GLN B 10
REMARK 475 LYS B 36
REMARK 475 HIS B 37
REMARK 475 ARG B 37A
REMARK 475 ARG B 37B
REMARK 475 SER B 37C
REMARK 475 PRO B 37D
REMARK 475 ASP B 110A
REMARK 475 GLY B 186C
REMARK 475 GLY B 186D
REMARK 475 PRO B 186E
REMARK 475 ARG B 243
REMARK 475 PRO B 244
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 GLN A 8 CB CG CD OE1 NE2
REMARK 480 GLN A 10 CB CG CD OE1 NE2
REMARK 480 LYS A 92 CG CD CE NZ
REMARK 480 LYS A 109 CB CG CD CE NZ
REMARK 480 ASP A 110A CB CG OD1 OD2
REMARK 480 SER A 110C C O
REMARK 480 GLN A 113 CG CD OE1 NE2
REMARK 480 LEU A 147 CA CB CG CD1 CD2
REMARK 480 GLN A 169B CG CD OE1 NE2
REMARK 480 GLN A 186F CB CG CD OE1 NE2
REMARK 480 LYS A 222 CG CD CE NZ
REMARK 480 ARG A 243 CB CG CD NE CZ NH1 NH2
REMARK 480 GLN B 5 CB CG CD OE1 NE2
REMARK 480 ARG B 60B CG CD NE CZ NH1 NH2
REMARK 480 LYS B 92 CG CD CE NZ
REMARK 480 LYS B 109 CB CG CD CE NZ
REMARK 480 SER B 110C C O
REMARK 480 ARG B 110D N CA C O
REMARK 480 GLN B 113 CG CD OE1 NE2
REMARK 480 LEU B 147 CB CG CD1 CD2
REMARK 480 GLN B 169B CG CD OE1 NE2
REMARK 480 GLN B 186F CB CG CD OE1 NE2
REMARK 480 ASP B 204 CG OD1 OD2
REMARK 480 LYS B 222 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 LEU B 199 N - CA - C ANGL. DEV. = -17.2 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PHE A 11 88.86 163.26
REMARK 500 LEU A 20 137.22 177.89
REMARK 500 PRO A 28 -1.18 -55.69
REMARK 500 HIS A 37 -165.89 -102.63
REMARK 500 HIS A 62 29.44 -72.00
REMARK 500 LYS A 92 -9.53 -55.96
REMARK 500 PHE A 94 101.07 -57.53
REMARK 500 ASP A 102 96.01 -68.62
REMARK 500 ILE A 103 144.57 -171.20
REMARK 500 CYS A 111 -80.03 -125.70
REMARK 500 GLN A 129 83.05 -154.33
REMARK 500 PRO A 131 176.80 -57.34
REMARK 500 TRP A 133 28.32 38.41
REMARK 500 GLU A 145 146.84 174.32
REMARK 500 ALA A 146 -76.05 -29.30
REMARK 500 LEU A 171 68.23 -113.09
REMARK 500 LEU A 172 39.21 37.86
REMARK 500 ASN A 173 -14.45 70.54
REMARK 500 SER A 186B -150.10 176.37
REMARK 500 PRO A 186E 76.82 -37.98
REMARK 500 GLN A 186F 129.89 66.08
REMARK 500 ASN A 203 116.31 -163.51
REMARK 500 LEU A 217 91.30 -64.92
REMARK 500 CYS A 220 89.36 -154.90
REMARK 500 LYS A 230 90.21 -68.19
REMARK 500 PRO B 9 95.71 -66.37
REMARK 500 GLN B 10 46.70 -83.73
REMARK 500 PHE B 11 118.18 -166.13
REMARK 500 LEU B 20 135.69 -173.79
REMARK 500 PRO B 28 0.44 -57.82
REMARK 500 ARG B 37A 104.92 -56.68
REMARK 500 SER B 49 -1.16 -47.05
REMARK 500 CYS B 50 16.61 -162.98
REMARK 500 GLU B 60A -17.47 -46.79
REMARK 500 PRO B 61 -41.63 -27.55
REMARK 500 LYS B 92 -8.10 -50.15
REMARK 500 PHE B 94 108.09 -48.92
REMARK 500 THR B 98 1.74 -160.93
REMARK 500 ASN B 101 35.52 80.20
REMARK 500 CYS B 111 -73.30 -82.26
REMARK 500 ALA B 126 -38.83 -33.62
REMARK 500 ASP B 127 35.07 -86.17
REMARK 500 PRO B 131 173.94 -56.10
REMARK 500 TRP B 133 24.18 41.48
REMARK 500 TYR B 141 34.80 -140.08
REMARK 500 ARG B 174 -154.83 -70.53
REMARK 500 ASP B 178 36.97 -76.71
REMARK 500 ARG B 186A 172.42 -57.03
REMARK 500 SER B 186B -152.76 173.06
REMARK 500 PRO B 186E 79.21 -40.06
REMARK 500
REMARK 500 THIS ENTRY HAS 55 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS DANSYL-GLU-GLY-ARG-CMK-
REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO
REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 195 FORMING A HEMIKETAL
REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: N-{[5-(DIMETHYLAMINO)NAPHTHALEN-2-YL]SULFONYL}-L-
REMARK 630 ALPHA-GLUTAMYL-N-[(1S)-4-{[AMINO(IMINIO)METHYL]AMINO}-1-
REMARK 630 (CHLOROACETYL) BUTYL]GLYCINAMIDE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 2Z0 A 245
REMARK 630 2Z0 B 245
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: DSY GLU GLY AR7 0QE
REMARK 630 DETAILS: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2Z0 A 245
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2Z0 B 245
DBREF 1BDA A 1 244 UNP P00750 TPA_HUMAN 298 562
DBREF 1BDA B 1 244 UNP P00750 TPA_HUMAN 298 562
SEQRES 1 A 265 THR CYS GLY LEU ARG GLN TYR SER GLN PRO GLN PHE ARG
SEQRES 2 A 265 ILE LYS GLY GLY LEU PHE ALA ASP ILE ALA SER HIS PRO
SEQRES 3 A 265 TRP GLN ALA ALA ILE PHE ALA LYS HIS ARG ARG SER PRO
SEQRES 4 A 265 GLY GLU ARG PHE LEU CYS GLY GLY ILE LEU ILE SER SER
SEQRES 5 A 265 CYS TRP ILE LEU SER ALA ALA HIS CYS PHE GLN GLU ARG
SEQRES 6 A 265 PHE PRO PRO HIS HIS LEU THR VAL ILE LEU GLY ARG THR
SEQRES 7 A 265 TYR ARG VAL VAL PRO GLY GLU GLU GLU GLN LYS PHE GLU
SEQRES 8 A 265 VAL GLU LYS TYR ILE VAL HIS LYS GLU PHE ASP ASP ASP
SEQRES 9 A 265 THR TYR ASP ASN ASP ILE ALA LEU LEU GLN LEU LYS SER
SEQRES 10 A 265 ASP SER SER ARG CYS ALA GLN GLU SER SER VAL VAL ARG
SEQRES 11 A 265 THR VAL CYS LEU PRO PRO ALA ASP LEU GLN LEU PRO ASP
SEQRES 12 A 265 TRP THR GLU CYS GLU LEU SER GLY TYR GLY LYS HIS GLU
SEQRES 13 A 265 ALA LEU SER PRO PHE TYR SER GLU ARG LEU LYS GLU ALA
SEQRES 14 A 265 HIS VAL ARG LEU TYR PRO SER SER ARG CYS THR SER GLN
SEQRES 15 A 265 HIS LEU LEU ASN ARG THR VAL THR ASP ASN MET LEU CYS
SEQRES 16 A 265 ALA GLY ASP THR ARG SER GLY GLY PRO GLN ALA ASN LEU
SEQRES 17 A 265 HIS ASP ALA CYS GLN GLY ASP SER GLY GLY PRO LEU VAL
SEQRES 18 A 265 CYS LEU ASN ASP GLY ARG MET THR LEU VAL GLY ILE ILE
SEQRES 19 A 265 SER TRP GLY LEU GLY CYS GLY GLN LYS ASP VAL PRO GLY
SEQRES 20 A 265 VAL TYR THR LYS VAL THR ASN TYR LEU ASP TRP ILE ARG
SEQRES 21 A 265 ASP ASN MET ARG PRO
SEQRES 1 B 265 THR CYS GLY LEU ARG GLN TYR SER GLN PRO GLN PHE ARG
SEQRES 2 B 265 ILE LYS GLY GLY LEU PHE ALA ASP ILE ALA SER HIS PRO
SEQRES 3 B 265 TRP GLN ALA ALA ILE PHE ALA LYS HIS ARG ARG SER PRO
SEQRES 4 B 265 GLY GLU ARG PHE LEU CYS GLY GLY ILE LEU ILE SER SER
SEQRES 5 B 265 CYS TRP ILE LEU SER ALA ALA HIS CYS PHE GLN GLU ARG
SEQRES 6 B 265 PHE PRO PRO HIS HIS LEU THR VAL ILE LEU GLY ARG THR
SEQRES 7 B 265 TYR ARG VAL VAL PRO GLY GLU GLU GLU GLN LYS PHE GLU
SEQRES 8 B 265 VAL GLU LYS TYR ILE VAL HIS LYS GLU PHE ASP ASP ASP
SEQRES 9 B 265 THR TYR ASP ASN ASP ILE ALA LEU LEU GLN LEU LYS SER
SEQRES 10 B 265 ASP SER SER ARG CYS ALA GLN GLU SER SER VAL VAL ARG
SEQRES 11 B 265 THR VAL CYS LEU PRO PRO ALA ASP LEU GLN LEU PRO ASP
SEQRES 12 B 265 TRP THR GLU CYS GLU LEU SER GLY TYR GLY LYS HIS GLU
SEQRES 13 B 265 ALA LEU SER PRO PHE TYR SER GLU ARG LEU LYS GLU ALA
SEQRES 14 B 265 HIS VAL ARG LEU TYR PRO SER SER ARG CYS THR SER GLN
SEQRES 15 B 265 HIS LEU LEU ASN ARG THR VAL THR ASP ASN MET LEU CYS
SEQRES 16 B 265 ALA GLY ASP THR ARG SER GLY GLY PRO GLN ALA ASN LEU
SEQRES 17 B 265 HIS ASP ALA CYS GLN GLY ASP SER GLY GLY PRO LEU VAL
SEQRES 18 B 265 CYS LEU ASN ASP GLY ARG MET THR LEU VAL GLY ILE ILE
SEQRES 19 B 265 SER TRP GLY LEU GLY CYS GLY GLN LYS ASP VAL PRO GLY
SEQRES 20 B 265 VAL TYR THR LYS VAL THR ASN TYR LEU ASP TRP ILE ARG
SEQRES 21 B 265 ASP ASN MET ARG PRO
HET 2Z0 A 245 41
HET 2Z0 B 245 41
HETNAM 2Z0 N-{[5-(DIMETHYLAMINO)NAPHTHALEN-2-YL]SULFONYL}-L-ALPHA-
HETNAM 2 2Z0 GLUTAMYL-N-[(1S)-4-{[AMINO(IMINIO)METHYL]AMINO}-1-
HETNAM 3 2Z0 (CHLOROACETYL) BUTYL]GLYCINAMIDE
HETSYN 2Z0 DANSYL-GLU-GLY-ARG-CHLOROMETHYL-KETONE
FORMUL 3 2Z0 2(C26 H37 CL N7 O7 S 1+)
FORMUL 5 HOH *19(H2 O)
HELIX 1 1 ILE A 24 HIS A 27 5 4
HELIX 2 2 HIS A 57 PHE A 59 5 3
HELIX 3 3 PRO A 61 HIS A 63 5 3
HELIX 4 4 SER A 165 ARG A 167 5 3
HELIX 5 5 VAL A 231 ASP A 240 5 10
HELIX 6 6 ILE B 24 HIS B 27 5 4
HELIX 7 7 ALA B 56 PHE B 59 5 4
HELIX 8 8 PRO B 61 HIS B 63 5 3
HELIX 9 9 SER B 165 ARG B 167 5 3
HELIX 10 10 VAL B 231 ASP B 240 1 10
SHEET 1 A 7 ALA A 31 ALA A 35 0
SHEET 2 A 7 LEU A 64 LEU A 68 -1 N ILE A 67 O ALA A 32
SHEET 3 A 7 GLN A 81 VAL A 90 -1 N PHE A 83 O VAL A 66
SHEET 4 A 7 ALA A 104 LYS A 109 -1 N LYS A 109 O GLU A 84
SHEET 5 A 7 TRP A 51 SER A 54 -1 N SER A 54 O ALA A 104
SHEET 6 A 7 GLU A 38 SER A 48 -1 N SER A 48 O TRP A 51
SHEET 7 A 7 GLN A 30 LYS A 36 -1 N ALA A 35 O ARG A 39
SHEET 1 B 6 LYS A 156 ARG A 161 0
SHEET 2 B 6 GLU A 135 GLY A 140 -1 N GLY A 140 O LYS A 156
SHEET 3 B 6 PRO A 198 ASN A 203 -1 N VAL A 200 O GLU A 137
SHEET 4 B 6 ARG A 206 TRP A 215 -1 N GLY A 211 O LEU A 199
SHEET 5 B 6 GLY A 226 LYS A 230 -1 N THR A 229 O ILE A 212
SHEET 6 B 6 MET A 180 ALA A 183 -1 N ALA A 183 O GLY A 226
SHEET 1 C 7 ALA B 31 ALA B 35 0
SHEET 2 C 7 LEU B 64 LEU B 68 -1 N ILE B 67 O ALA B 32
SHEET 3 C 7 GLN B 81 VAL B 90 -1 N PHE B 83 O VAL B 66
SHEET 4 C 7 ILE B 103 LYS B 109 -1 N LYS B 109 O GLU B 84
SHEET 5 C 7 TRP B 51 ALA B 55 -1 N SER B 54 O ALA B 104
SHEET 6 C 7 PHE B 40 SER B 48 -1 N SER B 48 O TRP B 51
SHEET 7 C 7 GLN B 30 PHE B 34 -1 N ILE B 33 O LEU B 41
SHEET 1 D 2 GLU B 135 GLY B 140 0
SHEET 2 D 2 LYS B 156 ARG B 161 -1 N VAL B 160 O CYS B 136
SHEET 1 E 4 MET B 180 ALA B 183 0
SHEET 2 E 4 GLY B 226 LYS B 230 -1 N TYR B 228 O LEU B 181
SHEET 3 E 4 ARG B 206 TRP B 215 -1 N TRP B 215 O VAL B 227
SHEET 4 E 4 PRO B 198 ASN B 203 -1 N ASN B 203 O ARG B 206
SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.02
SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.01
SSBOND 3 CYS A 50 CYS A 111 1555 1555 2.03
SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.03
SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.02
SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.03
SSBOND 7 CYS B 1 CYS B 122 1555 1555 2.02
SSBOND 8 CYS B 42 CYS B 58 1555 1555 2.03
SSBOND 9 CYS B 50 CYS B 111 1555 1555 2.03
SSBOND 10 CYS B 136 CYS B 201 1555 1555 2.03
SSBOND 11 CYS B 168 CYS B 182 1555 1555 2.02
SSBOND 12 CYS B 191 CYS B 220 1555 1555 2.01
LINK NE2 HIS A 57 CE 2Z0 A 245 1555 1555 1.52
LINK OG SER A 195 CC 2Z0 A 245 1555 1555 1.40
LINK NE2 HIS B 57 CE 2Z0 B 245 1555 1555 1.53
LINK OG SER B 195 CC 2Z0 B 245 1555 1555 1.42
SITE 1 AC1 15 HIS A 57 TYR A 99 ARG A 174 ASP A 189
SITE 2 AC1 15 ALA A 190 GLY A 193 SER A 195 SER A 214
SITE 3 AC1 15 TRP A 215 GLY A 216 GLY A 219 TRP B 133
SITE 4 AC1 15 TYR B 163 ARG B 167 ASP B 223
SITE 1 AC2 18 TRP A 133 TYR A 163 ARG A 167 ASP A 185
SITE 2 AC2 18 ASP A 223 HIS B 57 TYR B 99 ARG B 174
SITE 3 AC2 18 ASP B 189 ALA B 190 GLN B 192 GLY B 193
SITE 4 AC2 18 SER B 195 SER B 214 TRP B 215 GLY B 216
SITE 5 AC2 18 LEU B 217 GLY B 219
CRYST1 43.990 80.780 159.160 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022732 0.000000 0.000000 0.00000
SCALE2 0.000000 0.012379 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006283 0.00000
MTRIX1 1 -0.999957 -0.001563 -0.009178 22.41300 1
MTRIX2 1 0.001411 -0.999863 0.016518 64.09110 1
MTRIX3 1 -0.009203 0.016504 0.999821 -0.25990 1
MTRIX1 2 -0.998807 -0.037285 -0.031526 25.05300 1
MTRIX2 2 0.036553 -0.999055 0.023500 63.25160 1
MTRIX3 2 -0.032372 0.022320 0.999227 -0.29250 1